Therapeutic efficacy of antibody-drug conjugates targeting GD2-positive tumors.
Kalinovsky DV, Kibardin AV, Kholodenko IV, Svirshchevskaya EV, Doronin II, Konovalova MV, Grechikhina MV, Rozov FN, Larin SS, Deyev SM, Kholodenko RV.
Kalinovsky DV, et al. Among authors: grechikhina mv.
J Immunother Cancer. 2022 Jun;10(6):e004646. doi: 10.1136/jitc-2022-004646.
J Immunother Cancer. 2022.
PMID: 35764367
Free PMC article.